Rossari Biotech Limited (ROSSARI.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 20.96B |
| Enterprise Value | 24.4B |
| P/E Ratio | 16.39 |
| PEG Ratio | 1.42 |
| Price/Sales Ratio | 0.97 |
| Price/Book Ratio | 1.85 |
| Enterprise/Revenue | 0.97 |
| Enterprise/EBITDA | 7.63 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 23.96B |
| Revenue/Share | 460.64 |
| Gross Profit | 4.94B |
| EBITDA | 2.86B |
| Net Income | 1.49B |
| Diluted EPS | 26.93 |
Balance Sheet
| Total Cash | 1.15B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 240.87 |
Price History
| 52-Week Change | -29.85 |
| 52-Week High | 690.3 |
| 52-Week Low | 375 |
| Moving Average 50 Days | 502.16 |
| Moving Average 200 Days | 511.63 |
Statistics
| Average Volume | 99,957 |
| Shares Outstanding | 55.39M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 0.11 |
| Payout Ratio | 0.02 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
